GeneSight Mental Health Monitor Media Kit
2 Out of 3 Women With Depression or Anxiety Say They’ve Reached Their “Breaking Point,” Yet More than Half Wait a Year Before Seeking Treatment
Six in 10 of the women surveyed with depression or anxiety diagnosis say they have been ignored or dismissed by family, friends, and/or partners about their mental health concerns
Ansley Fancher can relate to the two thirds of women polled in the new GeneSight Mental Health Monitor nationwide survey who say they are at or near their breaking point. After trying to manage her depression and anxiety on her own, she began therapy and took the GeneSight test, which helped inform her clinician’s medication treatment decision. She is now studying to become a psychologist.
The GeneSight Mental Health Monitor is a nationwide survey of U.S. adults conducted online by ACUPOLL Precision Research, Inc. from Feb. 25 – March 11, 2022, among a statistically representative sample (n=1000) of adults age 18+. The survey included a representative sample of women diagnosed with depression and anxiety. The margin of error in survey results for the total base population at a 95% confidence interval is +/- 3%.